{"nct_id":"NCT04250350","title":"Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis","status":"COMPLETED","status_verified_date":"2023-01","start_date":"2020-02-11","start_date_type":"ACTUAL","primary_completion_date":"2022-04-20","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-22","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}